917. Adulteration and misbranding of digitalis tablets, misbranding of cascara compound tablets, alleged adulteration of cascara compound tablets, and alleged adulteration and misbranding of posterior pituitary solution. U. S. v. Buffalo Pharmacal Co., Inc., and Joseph H. Dotterweich. Counts charging adulteration of cascara compound tablets and adulteration and misbranding of posterior pituitary solution nolle prossed. Pleas of not guilty. Tried to the court and jury. Verdict of guilty as to the individual defendant; disagreement as to the corporate defendant. Fine, 500 on each of 3 counts against individual defendant; payment of fines on counts 2 and 3 suspended and the individual defendant placed on probation. Judgment reversed on appeal to the Circuit Court of Appeals. Petition for Writ of Certiorari granted and decision rendered by Supreme Court reversing the judgment of the Circuit Court of Appeals.

Case Number: 917 Collection: Drugs and Devices, 1940-1963 Evidence Numbers: F. D. C. Nos. 951, 2087. Sample Nos. 78710-D, 78786-D, 78814-D. Date Issued: October 1944 Seizure Dates: October 2, 1939, and January 8, 1940 Product Keywords: digitalis tablets; cascara compound tablets; cascara compound tablets; posterior pituitary solution Defendant Names: Buffalo Pharmacal Co., Inc., and Joseph H. Dotterweich, secretary and general manager of the corporation Court Jurisdiction: Western District of New York Seizure Location: Pennsylvania and Ohio Shipped From: New York Shipped To: Pennsylvania and Ohio Copyright: The National Library of Medicine believes this item to be in the public domain (More information)